To Increase Patient Access

Post Category: Research

February 8, 2024
Clinical Trial for Patients with Primary Central Nervous System Lymphoma (PCNSL)

Ono Pharma is actively recruiting patients with Primary Central Nervous System Lymphoma (PCNSL) for the PROSPECT Study, which is evaluating an oral medicine called Tirabrutinib.

Read More
January 29, 2024
Revolutionizing Cancer Care: Advances in Radiation Therapy for Brain Tumors

Modern radiation therapy for brain tumors, marked by precision, personalization, safety, and ongoing innovation, holds promise for enhancing patient outcomes and instilling hope in challenging diagnoses.

Read More
January 23, 2024
Clinical Study for Patients with Newly Diagnosed Metastatic Brain Tumors

The Roads Clinical Study is designed for patients diagnosed with a metastatic brain tumor.

Read More
January 9, 2024
ONLY FOUR SPOTS LEFT! Opportunity for Patients Living with rGBM

Patients and caregivers dealing with first recurrence glioblastoma are being sought for an important survey. Make your voice heard.

Read More
December 14, 2023
NEW SonALAsense Clinical Trials for rGBM & DIPG Patients

SonALAsense was founded to create hope in the face of despair with Sonodynamic Therapy (SDT), a non-invasive way to treat and eradicate deadly cancers.

Read More
November 16, 2023
 IGV-001 Phase 2b Clinical Trial

Imvax is conducting a clinical trial to assess the safety and efficacy of IGV-001, an autologous biologic-device combination product in GBM patients.

Read More
November 9, 2023
EBCI Attends SNO 2023

The End Brain Cancer Initiative team is proud to be attending the 2023 Society for Neuro-Oncology Annual Meeting (SNO)

Read More
October 20, 2023
Make YOUR Voice Heard! Raising Patient Voices with EBCI

Make your voice heard by participating in the NSCLC, LGG, or rGBM study. You will advance our understanding of the treatment and management of these diseases. 

Read More
October 19, 2023
Oncoheroes Gains FDA Approval for Pediatric Cancer Drug Trials

Oncoheroes Biosciences, Inc. has received the FDA's greenlight to proceed with two crucial clinical trials, which open the door to new drug treatments for pediatric cancer .

Read More
October 14, 2023
Living with Recurrent Glioblastoma

Patients and caregivers dealing with first recurrence glioblastoma are being sought for an important survey. Make your voice heard.

Read More
October 7, 2023
Low Grade Glioma Patients & Caregivers: Raise Your Voices!

Raise your voice. Take the low grade glioma survey. Register for the National Caregivers Online Event.

Read More
October 2, 2023
Have YOUR Voice Heard! EBCI Is Raising Patient Voices

Make your voice heard. Participate in a study to help advance our understanding of cancer treatment.

Read More
1 2 3 5


Enhancing patient outcomes by expanding FDA-approved treatment modalities and fueling research in the pharma/bio/life sciences, device & diagnostic industries and by closing the existing GAP from initial diagnosis to IMMEDIATE AND EXPANDED ACCESS to specialists, researchers, advanced & innovative treatments, clinical trials and critical care with the ultimate goal of improving patient outcomes through updating and improving WHO & NCCN Guidelines and clinical practices related to Standard of Care for brain cancer patients.

TAX ID:26-2185614
corporate partners
upcoming events
About us
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram